Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Pimecrolimus cream	TA82 - Tacrolimus and pimecrolimus for atopic eczema
Pirfenidone	TA282 - Pirfenidone for treating idiopathic pulmonary fibrosis	Hospital only
Pixantrone	TA306 - Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma	For hospital use only
Polatuzumab (Polivy®)	TA649 - Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma TA874 - Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma
Pomalidomide	TA427 - Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib	Hospital use only
Ponatinib	TA451 - Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia	For hospital use only
Prasugrel tablets	TA317 - Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes
Prucalopride	TA211 - Prucalopride for the treatment of chronic constipation in women	Available for use in men and women for chronic constipation.
Radium-223 (Xofigo®)	TA412 - Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases	Hospital only - NHSE commissioned
Raloxifene tablets	TA160 - Osteoporosis - secondary prevention including strontium ranelate TA161 - Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.